Search Results (252)
Click the Why column to see why an item matched the search.

MatchTypeWhy
Alani, RhodaPerson Why?
Melanoma brain metastasis: overview of current management and emerging targeted therapies.Academic Article Why?
Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas.Academic Article Why?
Protein kinase Cd is a therapeutic target in malignant melanoma with NRAS mutation.Academic Article Why?
MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.Academic Article Why?
Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis.Academic Article Why?
Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.Academic Article Why?
The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.Academic Article Why?
Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma.Academic Article Why?
Epigenetic Regulation of Resistance to Targeted Therapies in MelanomaGrant Why?
Adjuvant therapy of cutaneous malignant melanoma: a critical review.Academic Article Why?
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum.Academic Article Why?
Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.Academic Article Why?
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.Academic Article Why?
Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy.Academic Article Why?
First Prev Page of 17 Next Last Per PageĀ 
Highlights
Search Criteria
  • Melanoma
  • therapeutics
Filter by Type